Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy

Status Not yet recruiting

Clinical Trial Summary

This study tried to highlight the predictive value of the morning postoperative cortisol levels, which can act as the prognosis value of the postoperative pituitary function, providing future medication advices for improving patients' safety of drugs.

Clinical Trial Description

Transsphenoidal adenomectomy usually accompanied by the failure or recovery of the pituitary gland, which usually causing further hypopituitarism and hormone recovery. In order to prevent the potential applications of adrenal cortical malfunction after the surgery, many medical centers will use glucocorticoid supplements during the perioperative period care. However, this treatment might expose the normal hypothalamic-pituitary-adrenal (HPA) axis function patients into potential threats after the treatment of glucocorticoid supplements, such as bone loss, hypertension, emotional distress, and weight gain. To avoid unnecessary supply of glucocorticoids, the key question is to monitor the pituitary function. Thus, in this study we try to predict the morning postoperative cortisol levels, for further prediction of the postoperative pituitary function. To do so, we will review the retrospective charts of transsphenoidal adenomectomied patients from January, 2013 to April, 2018 in the NTUH Taipei. Use statistical methods analyzing all sorts of medical reports, including perioperative hormone thresholds.This study tried to highlight the predictive value of the morning postoperative cortisol levels, which can act as the prognosis value of the postoperative pituitary function, providing future medication advices for improving patients' safety of drugs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03708523
Study type	Observational
Source	National Taiwan University Hospital
Contact	Fon-Yih Tsuang
Phone	0972651142
Email	tsuangfy@gmail.com
Status	Not yet recruiting
Phase
Start date	November 1, 2018
Completion date	September 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02871986` - Pubertal Induction in Individuals With Hypogonadism	N/A
Completed	`NCT00851942` - Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test	Phase 4
Completed	`NCT00507104` - Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Completed	`NCT01088399` - A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults	N/A
Completed	`NCT00027430` - Androgen Replacement Therapy in Women With Hypopituitarism	N/A
Recruiting	`NCT04897802` - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)	Phase 4
Not yet recruiting	`NCT06014398` - Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours	N/A
Recruiting	`NCT04121780` - Growth Hormone Replacement Therapy for Retried Professional Football Players	Phase 2
Not yet recruiting	`NCT01666964` - Hormone Deficiency After Brain Injury During Combat	N/A
Completed	`NCT01028742` - Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity	N/A
Completed	`NCT00139945` - Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients	N/A
Completed	`NCT05206149` - Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes	Phase 4
Completed	`NCT05188131` - Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium	Phase 4
Completed	`NCT00133354` - Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys	Phase 2/Phase 3
Completed	`NCT01007071` - Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency	Phase 3
Not yet recruiting	`NCT06326853` - Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
Completed	`NCT00080483` - Testosterone and Growth Hormone for Bone Loss in Men	Phase 2
Completed	`NCT01009905` - An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)	N/A
Completed	`NCT01209416` - The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin	N/A
Completed	`NCT04902235` - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)	Phase 4